NIHR Bioresource: Advancing Rare Disease research with Omics technologies.

29 Jan 2026
Multi-Omics Integration Stage

About the project 

  • Developing a comprehensive multi-omics resource of 1,000 rare genetic disease patients 

  • Covers 15+ disease areas 

Omics datasets generated 

  • Genomics 

  • Short-read whole genome sequencing (30x coverage) 

  • Long-read whole genome sequencing (30x coverage) 

  • Transcriptomics 

  • RNA sequencing across 4 immune/hematopoietic cell types: Neutrophils, Monocytes, CD4 T-cells, Platelets 

  • Proteomics 

  • Mass spectrometry profiling on the 4 cell types + plasma 

  • Other data 

  • Whole blood counts

 Impact for Rare Disease Research 

  • First-in-kind deep multi-omics dataset across genomics, epigenomics, transcriptomics & proteomics 

  • Enables discovery of novel mechanisms and biomarkers 

  • Improves diagnostic yield and understanding of disease biology 

 

Speakers
Kathy Stirrups
Kathy Stirrups, Head of Samples - NIHR BioResource